A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
Clinical trial NCT04770896 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04770896
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-26
- Primary completion
- 2026-06-30
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.